High impact
The FDA selected Eli Lilly and Regeneron among the first seven companies for its PreCheck Pilot Program to accelerate review of new manufacturing facilities.
Finnhub06/30, 01:53 AM
- first seven companies
Figures as quoted by Finnhub
Related assets
Coming up for LLY
Explore next
Latest LLY news
Jin1008/17, 07:48 PM
Bloomberg08/13, 05:57 PM
FirstSquawk08/13, 12:08 PM
Berenberg raises Eli Lilly price target to $1,220 from $1,135.